
ABOUT
US
AfroCentric is the most diversified healthcare company in Southern Africa.
We are committed to making healthcare more affordable and widely accessible. Our transformed and integrated service offerings enable us to do this by optimising the healthcare value chain. Recently, we have grown our business through acquisitions to position us as a sustainable and leading healthcare Group.
By completing the integration of new acquisitions into our business and leveraging the power of technology to transform client service, we are moving closer to achieving our ultimate goal of transforming healthcare.
ABOUT AFROCENTRICLEADERSHIP
REVIEWS
CHAIRMAN’S REVIEW
CEO’S REVIEW
CFO’s REVIEW

CHAIRMAN’S review
The vital role played by companies within society was receiving growing recognition before the current crisis and must be emphasised even more at this time.
Indeed, all South Africans and South African companies, as patriotic citizens, must continue to band together to enable the country to emerge from the pandemic with a renewed strength and a clear sense of purpose to overcome our mounting challenges.
DR ANNA MOKGOKONG
CHAIRMAN’S REVIEW
CEO’S review
At the start of 2020, we could not have imagined the widespread impact of a virus yet to be named. Moreover, more than a year and a half on from our first hard lockdown, we find ourselves still in the riptide of the ongoing devastation.
The world needs the COVID-19 vaccines. A global effort has led to the successful development of multiple vaccines, and further cooperation is necessary to enable the optimum roll out of the vaccination process. There was never any doubt that AfroCentric would use the full might of our diversified business to answer this call.
AHMED BANDERKER
CEO’S REVIEW
CFO’S review
Aligning shareholders earnings and operating profit growth by maximising organic growth opportunities.
The 2021 Financial year will probably in future be known as the most uncertain time to do business in the world due to the changing trading conditions abroad and in South Africa.
HANNES BOONZAAIER
CFO’S REVIEW